Status:
COMPLETED
Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil
Lead Sponsor:
University of Sao Paulo
Conditions:
Infection
Eligibility:
MALE
35-45 years
Phase:
PHASE4
Brief Summary
Besides the specific response to vaccine antigens, the investigators will analyze the anti-HPV immune response in HIV-1-infected men in different strata of immune deficiency. The hypothesis will be te...
Detailed Description
The study will be divided into three groups. Patients with HIV-1 infection will be subdivided into groups according to T CD4 + lymphocytes at the time of vaccination: Over 500 CD4 T cells count and be...
Eligibility Criteria
Inclusion
- HIV
- Men with age between 35 and 45 years of age.
Exclusion
- Current or previous infection with human papillomavirus (HPV)
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02236234
Start Date
January 1 2012
End Date
January 1 2014
Last Update
September 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Tropical Medicine of Sao Paulo
São Paulo, São Paulo, Brazil, 05403000